Patients who received a combination of immunotherapy drugs lived longer than those who received standard chemotherapy treatment.
Affecting over 32.5 million adults in the United States, osteoarthritis is one of the leading disabling diseases and the most common form of arthritis.
Patients who received a combination of immunotherapy drugs lived longer than those who received standard chemotherapy treatment.
Affecting over 32.5 million adults in the United States, osteoarthritis is one of the leading disabling diseases and the most common form of arthritis.